Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Plos Pathogens|July 7, 2009
Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primatesSoumitra Roy, Luk H Vandenberghe, Sergey Kryazhimskiy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degenerationTimothy K Maclachlan, Michael Lukason, Margaret Collins, et al.
Journal of Virology|May 16, 2014
Increased mucosal CD4+ T cell activation in rhesus macaques following vaccination with an adenoviral vectorIrene Bukh, Roberto Calcedo, Soumitra Roy, et al.
Nature Medicine|July 18, 2006
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsidLuk H Vandenberghe, Lili Wang, Suryanarayan Somanathan, et al.
Molecular Therapy. Methods & Clinical Development|December 15, 2018
AAV8 Gene Therapy for Crigler-Najjar Syndrome in Macaques Elicited Transgene T Cell Responses That Are Resident to the LiverJenny A Greig, Roberto Calcedo, Leticia Kuri-Cervantes, et al.
Science Translational Medicine|June 24, 2011
Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkeyLuk H Vandenberghe, Peter Bell, Albert M Maguire, et al.
Human Gene Therapy. Clinical Development|October 13, 2017
Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3-Mutant DogsGuo-Jie Ye, András M Komáromy, Caroline Zeiss, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapyMark L Brantly, Jeffrey D Chulay, Lili Wang, et al.
Gene Therapy|October 13, 2023
Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaquesAlexander Kistner, Jessica A Chichester, Lili Wang, et al.
Pageof 8